A retrospective analysis examines the rarity of xylazine poisoning in France, suggesting improved surveillance is necessary.
This retrospective analysis highlights the rarity of reported xylazine exposures in French poison centre data, strengthened toxicological surveillance and coordination between Poison Control Center and drug-checking networks are needed to detect any shift toward broader use and guide prevention efforts.
No takes yet. Share an insight, caveat, or question.
Denis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: